Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Latanoprost is a commonly used treatment for glaucoma. Because of its mechanism of action, it is plausible that the age of a patient using the medication may affect its efficacy and time of onset.

We are going to study the effectiveness of Latanoprost in people of different ages, to see if it changes based on the age of the patient.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Collaborator: Pfizer
• Treatments: Latanoprost

Criteria

Inclusion Criteria:

• diagnosis of open angle glaucoma,

• pseudoexfoliation glaucoma, pigmentary glaucoma or ocular hypertension in one or both eyes;

• IOP above their target pressure as determined by a glaucoma specialist;

• willingness to participate in the study.

Exclusion Criteria:

• hypersensitivity to any of the components of the treatment medication;

• previous use of topical prostaglandins;

• documented ocular infection or intraocular inflammation within the past year;

• previous filtering surgery or complicated cataract surgery;

• active corneal disease;

• presence of cystoid macular edema;

• laser trabeculoplasty or any other ocular laser procedure within the past three months.